Other OTC Pharmaceuticals - Paraguay

  • Paraguay
  • In Paraguay, the revenue generated in the market Other OTC Pharmaceuticals amounts to US$22.10m in 2024.
  • It is projected to grow annually by 2.11% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,171.00m in 2024.
  • In terms of per person revenue, in Paraguay generates US$3.18 in 2024.
  • Paraguay's Other OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

Region comparison

Analyst Opinion

The Other OTC Pharmaceuticals market in Paraguay is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Paraguay are driving the growth of the Other OTC Pharmaceuticals market. Consumers in Paraguay are increasingly seeking self-care solutions and over-the-counter medications for minor ailments. This preference for self-medication is fueled by the convenience and accessibility of OTC products, as well as the desire to avoid the cost and hassle of visiting a doctor for minor health issues. Additionally, consumers in Paraguay value the ability to make their own healthcare decisions and take control of their well-being. Trends in the market are also contributing to the growth of the Other OTC Pharmaceuticals market in Paraguay. One major trend is the increasing availability and variety of OTC medications in pharmacies and supermarkets. This expansion of product offerings gives consumers more options to choose from and increases their awareness of OTC options. Additionally, there is a growing trend towards natural and herbal remedies, as consumers in Paraguay seek more holistic and alternative healthcare solutions. This trend is driving the demand for OTC products that are derived from natural ingredients and have fewer side effects.Local special circumstances in Paraguay are also playing a role in the development of the Other OTC Pharmaceuticals market. Paraguay has a relatively low doctor-to-patient ratio, which means that access to healthcare professionals can be limited, especially in rural areas. This lack of access to healthcare services further drives the demand for OTC medications as consumers rely on self-care for their health needs. Additionally, Paraguay has a growing middle class with increasing disposable income, which allows consumers to afford OTC medications and invest in their own health.Underlying macroeconomic factors are supporting the growth of the Other OTC Pharmaceuticals market in Paraguay. The country has experienced stable economic growth in recent years, which has led to an increase in consumer spending power. This economic stability has created a favorable environment for the development and expansion of the OTC Pharmaceuticals market. Additionally, the government of Paraguay has implemented policies to promote and regulate the OTC market, which has further contributed to its growth.In conclusion, the Other OTC Pharmaceuticals market in Paraguay is experiencing steady growth due to customer preferences for self-care, trends in the market such as the availability of OTC medications and the demand for natural remedies, local special circumstances such as limited access to healthcare services and a growing middle class, and underlying macroeconomic factors including stable economic growth and government policies.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)